Found: 9
Select item for more details and to access through your institution.
Brodalumab Is Associated with High Rates of Complete Clearance and Quality of Life Improvement: A Subgroup Analysis of Patients with Psoriasis and Concomitant Psoriatic Arthritis.
- Published in:
- Dermatology (10188665), 2022, v. 238, n. 4, p. 620, doi. 10.1159/000520290
- By:
- Publication type:
- Article
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 6, p. 2107, doi. 10.1007/s13555-021-00616-7
- By:
- Publication type:
- Article
Increased Skin Clearance and Quality of Life Improvement with Brodalumab Compared with Ustekinumab in Psoriasis Patients with Aggravating Lifestyle Factors.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 6, p. 2027, doi. 10.1007/s13555-021-00618-5
- By:
- Publication type:
- Article
Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL).
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 5, p. 1099, doi. 10.1007/s13555-020-00428-1
- By:
- Publication type:
- Article
Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Proliferation and Mitogenic Response to PDGF-BB of Fibroblasts Isolated from Chronic Venous Leg Ulcers is Ulcer-Age Dependent<sup>1</sup>.
- Published in:
- Journal of Investigative Dermatology, 1999, v. 112, n. 4, p. 463, doi. 10.1046/j.1523-1747.1999.00549.x
- By:
- Publication type:
- Article
Insulin Detemir Maintains Body Weight and Reduces Hypoglycemia While Improving Glycemic Control in Type 1 and 2 Patients: 6-Month Results from Predictive™.
- Published in:
- Diabetes, 2007, v. 56, p. A575
- By:
- Publication type:
- Article
Safety and Efficacy of Insulin Detemir Treatment in Elderly Type 2 Patients: 6-Month Results from PREDICTIVE™.
- Published in:
- Diabetes, 2007, v. 56, p. A557
- By:
- Publication type:
- Article
Switching Patients with Type 1 and Type 2 Diabetes on Basal-Bolus Regimen from Twice-Daily NPH to Once-Daily Insulin Detemir Leads to Improved Control and Safety.
- Published in:
- Diabetes, 2007, v. 56, p. A544
- By:
- Publication type:
- Article